Abstract:Abstract Introduction: Lung cancers demonstrate the highest number of p53 mutations of any cancer with 70% of small cell lung cancers and 33% of adenocarcinomas containing a mutation. Loss of p53 function has been correlated with therapeutic resistance and poor clinical outcomes. Therefore, developing therapeutic strategies that specifically target p53 loss-of-function mutants is of the utmost importance. The purpose of this investigation is to explore whether p53 status has impact on the radio-sensitizing effect of a DNA-PKcs inhibitor (NU7441). Methods: Clonogenic surviving fraction analysis, DNA double strand break repair kinetics, cell cycle analysis, immunofluorescence, immunoblot, apoptosis and autophagy assays were used to investigate the mechanism of radiosensitization of NU7441 in NSCLC cell lines (A549, H1299, and H460) with differential levels of p53 expression. Results: NU7441 substantially inhibited the repair of IR-induced DNA double strand break (DSB) in all three cell lines. Clonogenic surviving fraction analysis reveals that NU7441 is a better radio-sensitizer in p53-deficient cells (H1299) when compared to p53-wild type cells (A549, H460). Combination of ionizing radiation (IR) and NU7441 leads to a more robust G2 arrest in A549 and H460 cells when compared to radiation treatment only. However, NU7441 and radiation preferentially induced mitotic arrest in H1299 consequently leading to a significant increase in mitotic catastrophe. Furthermore, NU7441 led to an increase in apoptosis rather than autophagy as the predominant cell death pathway in p53-deficient cells. Moreover, knockdown of p53 using siRNA sensitized A549 to NU7441+IR treatment. Conclusion: Our study clearly shows that NU7441, a novel DNA-PKcs inhibitor, is a potent radio-sensitizer in p53-dificient lung cancer cells and highlights the promise of NU7441 in targeted cancer treatment. Citation Format: Yu Lan, Zengfu Shang, Feng-Ming Hsu, Vasu Tumati, Benjamin P. Chen, Debabrata Saha. NSCLC cells demonstrate differential mode of cell death in response to the combined treatment of radiation and a DNA-PKcs inhibitor. [abstract]. In: Proceedings of the 105th Annual Meeting of the American Association for Cancer Research; 2014 Apr 5-9; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2014;74(19 Suppl):Abstract nr 4911. doi:10.1158/1538-7445.AM2014-4911

DNA-PKcs Inhibition Sensitizes Cancer Cells to Carbon-Ion Irradiation Via Telomere Capping Disruption.

Icotinib Hydrochloride Enhances Chemo- And Radiosensitivity By Inhibiting Egfr Signaling And Attenuating Rad51 Expression And Function In Hela S3 Cells

Inhibition of DNA-PKcs Enhances Radiosensitivity and Increases the Levels of ATM and ATR in NSCLC Cells Exposed to Carbon Ion Irradiation.

DNA-PKcs Inhibition Sensitizes Human Chondrosarcoma Cells to Carbon Ion Irradiation via Cell Cycle Arrest and Telomere Capping Disruption

Telomere-Mitochondrion Links Contribute to Induction of Senescence in MCF-7 Cells after Carbon-Ion Irradiation.

Inhibition of key DNA double strand break repair protein kinases enhances radiosensitivity of head and neck cancer cells to X-ray and proton irradiation

Repair-independent functions of DNA-PKcs protect irradiated cells from mitotic slippage and accelerated senescence

Inhibition of DNA‑PK Activity Sensitizes A549 Cells to X‑ray Irradiation by Inducing the ATM‑dependent DNA Damage Response

Carbon Ions Trigger DNA Damage Response to Overcome Radioresistance by Regulating Β‐catenin Signaling in Quiescent HeLa Cells

IKKβ Regulates the Repair of DNA Double-Strand Breaks Induced by Ionizing Radiation in MCF-7 Breast Cancer Cells.

Targeted Inhibition of DNA-PKcs, ATM, ATR, PARP, and Rad51 Modulate Response to X Rays and Protons

NSCLC cells demonstrate differential mode of cell death in response to the combined treatment of radiation and a DNA-PKcs inhibitor.

DNA-PKcs Subunits in Radiosensitization by Hyperthermia on Hepatocellular Carcinoma Hepg2 Cell Line.

DNA-PKcs Deficiency Inhibits Glioblastoma Cell-Derived Angiogenesis after Ionizing Radiation.

DNA-PKcs Deficiency Sensitizes the Human Hepatoma HepG2 Cells to Cisplatin and 5-Fluorouracil Through Suppression of the PI3K/Akt/NF-κB Pathway

Genistein Sensitizes Glioblastoma Cells to Carbon Ions Via Inhibiting DNA-PKcs Phosphorylation and Subsequently Repressing NHEJ and Delaying HR Repair Pathways.

The Effect of Co-Inhibition of Ku80 and DNA-PKcs on Radiobiological Function of HeLa Cells

DNA-PKcs Functions in Cellular Hyper-Radiosensitivity

Comparable radiation sensitivity in p53 wild-type and p53 deficient tumor cells associated with different cell death modalities

Abstract 4911: NSCLC Cells Demonstrate Differential Mode of Cell Death in Response to the Combined Treatment of Radiation and a DNA-PKcs Inhibitor

Inhibition of EGFR Nuclear Translocation Attenuate Radioresistance Through Decreased P-Dna-pk Expression in Cervical Cancer Cells.